Literature DB >> 18451102

Epigenetic control: slow and global, nimble and local.

Christine S Cheng1, Tracy L Johnson, Alexander Hoffmann.   

Abstract

The regulation of gene expression involves multiple levels of control, from those that are inheritable to those that are highly responsive to environmental changes. In this issue of Genes & Development, Dong and colleagues (pp. 1159-1173) demonstrate that the dynamically controlled immune response transcription factor NF-kappaB may, in fact, have a role in regulating heterochromatin and gene expression at large distances from its actual target sequences and genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451102      PMCID: PMC2732403          DOI: 10.1101/gad.1677008

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  35 in total

Review 1.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

2.  The nucleation and maintenance of heterochromatin by a histone deacetylase in fission yeast.

Authors:  Takatomi Yamada; Wolfgang Fischle; Tomoyasu Sugiyama; C David Allis; Shiv I S Grewal
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

3.  Swi6/HP1 recruits a JmjC domain protein to facilitate transcription of heterochromatic repeats.

Authors:  Martin Zofall; Shiv I S Grewal
Journal:  Mol Cell       Date:  2006-06-09       Impact factor: 17.970

Review 4.  Insulators: exploiting transcriptional and epigenetic mechanisms.

Authors:  Miklos Gaszner; Gary Felsenfeld
Journal:  Nat Rev Genet       Date:  2006-08-15       Impact factor: 53.242

Review 5.  Heterochromatin revisited.

Authors:  Shiv I S Grewal; Songtao Jia
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

Review 6.  Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response.

Authors:  Michael G Rosenfeld; Victoria V Lunyak; Christopher K Glass
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

Review 7.  Nuclear reprogramming and pluripotency.

Authors:  Konrad Hochedlinger; Rudolf Jaenisch
Journal:  Nature       Date:  2006-06-29       Impact factor: 49.962

8.  Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300.

Authors:  H Zhong; R E Voll; S Ghosh
Journal:  Mol Cell       Date:  1998-04       Impact factor: 17.970

Review 9.  Yeast heterochromatin: regulation of its assembly and inheritance by histones.

Authors:  M Grunstein
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

10.  Stimulus specificity of gene expression programs determined by temporal control of IKK activity.

Authors:  Shannon L Werner; Derren Barken; Alexander Hoffmann
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

View more
  4 in total

1.  New insights into NF-kappaB regulation and function.

Authors:  Shao-Cong Sun; Steven C Ley
Journal:  Trends Immunol       Date:  2008-09-03       Impact factor: 16.687

2.  Presenilin controls CBP levels in the adult Drosophila central nervous system.

Authors:  Randy S Boyles; Kathryn M Lantz; Steven Poertner; Stephanie J Georges; Andrew J Andres
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

3.  Dissecting the Regulatory Strategies of NF-κB RelA Target Genes in the Inflammatory Response Reveals Differential Transactivation Logics.

Authors:  Kim A Ngo; Kensei Kishimoto; Jeremy Davis-Turak; Aditya Pimplaskar; Zhang Cheng; Roberto Spreafico; Emily Y Chen; Amy Tam; Gourisankar Ghosh; Simon Mitchell; Alexander Hoffmann
Journal:  Cell Rep       Date:  2020-02-25       Impact factor: 9.423

Review 4.  Epigenetic modifications in rheumatoid arthritis.

Authors:  Simon Strietholt; Britta Maurer; Marvin A Peters; Thomas Pap; Steffen Gay
Journal:  Arthritis Res Ther       Date:  2008-10-10       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.